glp 1 and addiction GLP-1 receptor agonists show promise in treating substance use disorders GLP-1 medications get at the

When levels fall below the clinical threshold, men develop symptoms of hypogonadism that can significantly impact quality of life

A new strategy of CyberKnife treatment system based radiosurgery followed by early use of adjuvant bevacizumab treatment for brain metastasis with extensive cerebral edema

Research suggests glutathione supplementation may help improve insulin resistance, reduce cell damage in fatty liver disease, and increase mobility for people with peripheral artery disease

This licence extension means that Toujeo will now be available to all eligible diabetes patients from six years and above in Ireland

As regulatory agencies continue to monitor the safety and efficacy of these medications, the GLP-1 market is expected to grow significantly, potentially reaching $50 billion annually by 2030

single determination